United-Guardian, Inc. (NASDAQ:UG – Get Free Report) saw a large drop in short interest during the month of September. As of September 30th, there was short interest totaling 12,413 shares, a drop of 37.4% from the September 15th total of 19,823 shares. Based on an average trading volume of 7,190 shares, the days-to-cover ratio is currently 1.7 days. Approximately 0.4% of the shares of the company are short sold.
United-Guardian Trading Down 0.1%
Shares of UG stock opened at $6.84 on Friday. The stock has a market capitalization of $31.42 million, a P/E ratio of 12.67 and a beta of 0.95. The firm’s 50 day moving average is $7.12 and its 200 day moving average is $7.08. United-Guardian has a 12 month low of $5.58 and a 12 month high of $8.45.
United-Guardian (NASDAQ:UG – Get Free Report) last released its quarterly earnings data on Friday, August 7th. The company reported $0.16 EPS for the quarter. United-Guardian had a net margin of 22.01% and a return on equity of 22.24%. The company had revenue of $3.11 million during the quarter.
Wall Street Analysts Forecast Growth
Read Our Latest Stock Report on UG
Institutional Investors Weigh In On United-Guardian
Several institutional investors have recently made changes to their positions in UG. Gamco Investors INC. ET AL boosted its holdings in shares of United-Guardian by 1.2% in the first quarter. Gamco Investors INC. ET AL now owns 164,388 shares of the company’s stock worth $1,101,000 after acquiring an additional 1,888 shares during the period. United Capital Financial Advisors LLC purchased a new position in shares of United-Guardian in the second quarter valued at $143,000. Finally, BlackRock Inc. bought a new stake in shares of United-Guardian during the 2nd quarter valued at $105,000. Hedge funds and other institutional investors own 23.16% of the company’s stock.
About United-Guardian
United-Guardian, Inc develops, manufactures, and markets specialty chemical products for the personal care, pharmaceutical, medical, and industrial markets. The company sells its products under proprietary and customer-specific brands, and works with distributors and manufacturers in the United States and international markets.
Its personal care products include Lubrajel water-soluble gel formulations and other specialty ingredients used in skin-care, hair-care, cosmetic, and personal hygiene products.
See Also
- Five stocks we like better than United-Guardian
- Rocket Lab’s Neutron Delay Leaves Wall Street Bullish But Raises the Stakes for 2027
- ManpowerGroup Stock Sinks on Q3 Results, But Fundamentals Stay Solid
- Does the AI Selloff Put Alphabet’s Breakout in Doubt?
- Bank Earnings Are Mixed—These 2 ETFs Offer Very Different Paths to a Recovery
Receive News & Ratings for United-Guardian Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for United-Guardian and related companies with MarketBeat.com's FREE daily email newsletter.
